New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2013
16:34 EDTSZYMSolazyme reports Q4 non-GAAP EPS (35c), consensus (37c)
Reports Q4 revenue $8.42M, consensus $9.28M.
News For SZYM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 2, 2015
18:04 EDTSZYMSolazyme files to delay Form 10-K
The company expects to file the subject report on Form 10-K for the fiscal year ended December 31, 2014 on or before the fifteenth calendar day following the due date. The Form 10-K could not be filed by the date required due to unanticipated delays in assembling all information required to complete the audited financial statements that are required to be included in the Form 10-K.
February 26, 2015
16:23 EDTSZYMSolazyme reports Q4 EPS (57c), consensus (47c)
Reports Q4 revenue $14.5M, consensus $17.7M.
February 25, 2015
05:11 EDTSZYMSolazyme receives FDA GRAS No Questions Letter for high oleic algae oil
Solazyme announced that the FDA has issued a favorable response to Solazyme’s notification which concludes that high-oleic algae oil is Generally Recognized as Safe as an ingredient in food products under the intended conditions of use. This No Questions letter will further pave the way for mainstream adoption of superior quality oleic algae oil with unprecedented functional, performance and nutritional benefits, enabling the creation of new products that meet consumer demand for healthy, sustainable ingredients. Solazyme has also received FDA No Questions letters for the whole food ingredient products currently offered within the AlgaVia portfolio, including Whole Algal Protein and Whole Algal Flour.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use